MESO

Mesoblast Limited

Healthcare›Biotechnology|NASDAQ Global Select|AU

Price

$14.81

Market Cap

$1.91B

Beta

0.85

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+191.39%

EPS Growth (YoY)+4.55%

Revenue CAGR 3Y+18.98%

P/E Ratio0.0

PEG Ratio—

FCF Yield-3.08%

Debt / Equity0.24

Interest Coverage-10.3x

No credit card required

Already have an account? Sign in to view the full analysis for MESO.